| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.019 | 1 |